XML 150 R141.htm IDEA: XBRL DOCUMENT v3.25.2
Net financial results (Details) - BRL (R$)
R$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Financial expenses [Abstract]        
Interest on loans, financing and debentures (1)     R$ (2,733,269) R$ (1,743,417)
Amortization of transaction costs     (48,174) (39,616)
Interest expenses on lease liabilities (2)     (230,308) (222,185)
Other     (234,773) (278,075)
Financial expenses     (3,246,524) (2,283,293)
Financial income [Abstract]        
Cash and cash equivalents and marketable securities     702,662 819,082
Other     119,450 62,023
Financial income     822,112 881,105
Results from derivative financial instruments [Abstract]        
Income     7,015,340 824,285
Expenses     (662,835) (5,349,163)
Derivative financial instruments, net R$ 2,659,346 R$ (3,890,341) 6,352,505 (4,524,878)
Monetary and exchange rate variations, net [Abstract]        
Exchange rate variations on loans, financing and debentures     9,147,254 (9,383,027)
Leases     322,483 (329,505)
Other assets and liabilities (3)     (1,276,652) 1,525,875
Monetary and exchange variations, net R$ 2,988,799 R$ (6,487,329) 8,193,085 (8,186,657)
Net financial result     12,121,178 (14,113,723)
Interest costs capitalised     126,119 802,515
Reclassification to biological assets     R$ 133,133 R$ 104,137